skip to main content

News and Events

Recent Releases

06/15/2018 - 2:45pm

Tumor cells reprogram metabolic pathways in order to grow

Researchers at the U-M Rogel Cancer Center have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.
06/07/2018 - 7:15am

U-M partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers

The University of Michigan Rogel Cancer Center has partnered with 69 other National Cancer Institute-designated cancer centers to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer.

06/06/2018 - 12:45pm

Personalizing Lung Cancer Screening

A new study shows how to personalize the lung cancer screening decision for every patient. The results could help doctors fine-tune their advice to patients so that it’s based not only on a patient’s individual lung cancer risk and the potential benefits and harms of screening, but also the patient’s attitude about looking for problems and dealing with the consequences.
06/06/2018 - 1:00am

U-M Rogel Cancer Center first in Michigan to offer all FDA approved CAR T-cell therapies

Media contact: Jessica Webster-Sendra734-764-2220 |  Patients may contact Cancer AnswerLine, 800-865-1125

ANN ARBOR, Michigan — With the recently announced FDA approval of Kymriah to treat adults with lymphoma, the University of Michigan Rogel Cancer Center is the first center in Michigan to offer all currently available CAR T-cell therapies.

05/20/2018 - 1:30am

Rogel Cancer Center at the 2018 ASCO Annual Meeting

Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Clinical Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.

All Releases